Cutler Group LLC / CA - PROGENICS PHARMACEUTICALS IN ownership

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 121 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2015. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cutler Group LLC / CA ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2017$1,000
-80.0%
600
-92.7%
0.00%
Q2 2017$5,000
-93.5%
8,200
-94.7%
0.00%
-100.0%
Q1 2017$77,000
+1440.0%
154,000
+5316.8%
0.00%
Q4 2016$5,000
+400.0%
2,843
-75.3%
0.00%
Q3 2016$1,000
-80.0%
11,500
+296.6%
0.00%
Q2 2016$5,000
-86.8%
2,900
-76.2%
0.00%
-100.0%
Q1 2016$38,000
-24.0%
12,200
-5.4%
0.00%
+50.0%
Q4 2015$50,00012,9000.00%
Other shareholders
PROGENICS PHARMACEUTICALS IN shareholders Q4 2015
NameSharesValueWeighting ↓
EVERENCE CAPITAL MANAGEMENT INC 28,980$123,0000.01%
Daiwa Securities Group Inc. 533$2,0000.00%
IFP Advisors, Inc 0$00.00%
NEW YORK STATE TEACHERS RETIREMENT SYSTEM 138,663$52,0000.00%
View complete list of PROGENICS PHARMACEUTICALS IN shareholders